Exciting News!
We’re pleased to share that NeoMega36 has now been notified in Spain — an important step forward in making this innovation more widely available to clinicians and preterm infants across Europe.
NeoMega36 is specifically developed to support the development of normal visual function in preterm infants, contributing to healthier starts and brighter futures for the most vulnerable newborns.
We’re grateful to our dedicated teams and partners in Spain who helped make this possible.
More to come as we continue expanding access and impact.